PDB Short entry for 5V54 HEADER ELECTRON TRANSPORT 13-MAR-17 5V54 TITLE CRYSTAL STRUCTURE OF 5-HT1B RECEPTOR IN COMPLEX WITH METHIOTHEPIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5-HYDROXYTRYPTAMINE RECEPTOR 1B,OB-1 FUSED 5-HT1B RECEPTOR, COMPND 3 5-HYDROXYTRYPTAMINE RECEPTOR 1B; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: UNP RESIDUES 37-239,UNP RESIDUES 304-390; COMPND 6 SYNONYM: 5-HT1B,S12,SEROTONIN 1D BETA RECEPTOR,5-HT-1D-BETA,SEROTONIN COMPND 7 RECEPTOR 1B; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, SPODOPTERA FRUGIPERDA; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 7108; SOURCE 5 GENE: HTR1B, HTR1DB; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9 KEYWDS 5-HYDROXYTRYPTAMINE, GPCR ANTAGONIST, OB1, ELECTRON TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR W.C.YIN,X.E.ZHOU,D.YANG,P.DE WAAL,M.T.WANG,A.DAI,X.CAI,C.Y.HUANG, AUTHOR 2 P.LIU,Y.YIN,B.LIU,M.CAFFREY,K.MELCHER,Y.XU,M.W.WANG,H.E.XU,Y.JIANG REVDAT 1 07-FEB-18 5V54 0 JRNL AUTH W.C.YIN,X.E.ZHOU,D.YANG,P.DE WAAL,M.T.WANG,A.DAI,X.CAI, JRNL AUTH 2 C.Y.HUANG,P.LIU,Y.YIN,B.LIU,M.CAFFREY,K.MELCHER,Y.XU, JRNL AUTH 3 M.W.WANG,H.E.XU,Y.JIANG JRNL TITL A COMMON ANTAGONISTIC MECHANISM FOR CLASS A GPCRS REVEALED JRNL TITL 2 BY THE STRUCTURE OF THE HUMAN 5-HT1B SEROTONIN RECEPTOR JRNL TITL 3 BOUND TO AN ANTAGONIST JRNL REF CELL DISCOV 2018 JRNL REFN ESSN 2056-5968 REMARK 2 REMARK 2 RESOLUTION. 3.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.51 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 11996 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.273 REMARK 3 R VALUE (WORKING SET) : 0.272 REMARK 3 FREE R VALUE : 0.288 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.140 REMARK 3 FREE R VALUE TEST SET COUNT : 857 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.5094 - 8.3868 0.99 1221 78 0.2224 0.2177 REMARK 3 2 8.3868 - 6.6635 1.00 1164 91 0.2471 0.2875 REMARK 3 3 6.6635 - 5.8232 0.99 1145 101 0.2871 0.2932 REMARK 3 4 5.8232 - 5.2916 0.99 1129 86 0.2771 0.2841 REMARK 3 5 5.2916 - 4.9128 0.97 1101 82 0.2923 0.2869 REMARK 3 6 4.9128 - 4.6235 0.97 1104 91 0.2733 0.2857 REMARK 3 7 4.6235 - 4.3921 0.99 1140 74 0.3100 0.3516 REMARK 3 8 4.3921 - 4.2011 0.98 1110 85 0.3544 0.4284 REMARK 3 9 4.2011 - 4.0394 0.94 1041 98 0.4049 0.4082 REMARK 3 10 4.0394 - 3.9001 0.85 984 71 0.4211 0.4278 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.650 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 39.690 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 6332 REMARK 3 ANGLE : 1.097 8627 REMARK 3 CHIRALITY : 0.043 1009 REMARK 3 PLANARITY : 0.006 1056 REMARK 3 DIHEDRAL : 12.362 2283 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5V54 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-MAY-17. REMARK 100 THE DEPOSITION ID IS D_1000226892. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-MAY-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12888 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.800 REMARK 200 RESOLUTION RANGE LOW (A) : 45.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.3700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM BIS-TRIS (PH7.0), 155MM AMMONIUM REMARK 280 PHOSPHATE MONOBASIC, 26% PEG300, 0.01M GSH (L-GLUTATHIONE REMARK 280 REDUCED), GSSG (L-GLUTATHIONE OXIDIZED), LIPIDIC CUBIC PHASE, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 117.60000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.41500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 117.60000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.41500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1970 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 40390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 37 REMARK 465 ALA A 192 REMARK 465 GLU A 193 REMARK 465 GLU A 194 REMARK 465 GLU A 195 REMARK 465 VAL A 196 REMARK 465 LYS A 341 REMARK 465 ASP A 342 REMARK 465 ALA A 343 REMARK 465 CYS A 344 REMARK 465 TRP A 345 REMARK 465 THR A 389 REMARK 465 SER A 390 REMARK 465 ALA B 1047 REMARK 465 LEU B 1048 REMARK 465 GLU B 1049 REMARK 465 ASP B 1050 REMARK 465 ARG B 1051 REMARK 465 LYS B 341 REMARK 465 ASP B 342 REMARK 465 ALA B 343 REMARK 465 CYS B 344 REMARK 465 TRP B 345 REMARK 465 THR B 389 REMARK 465 SER B 390 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 100 -67.46 -104.90 REMARK 500 PHE A 217 -68.15 -106.04 REMARK 500 ILE B 100 -67.65 -104.90 REMARK 500 PHE B 217 -68.61 -105.72 REMARK 500 LEU B1106 20.37 -64.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 89F A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 89F B 1201 DBREF 5V54 A 37 239 UNP P28222 5HT1B_HUMAN 37 239 DBREF 5V54 A 1001 1105 PDB 5V54 5V54 1001 1105 DBREF 5V54 A 1106 390 UNP P28222 5HT1B_HUMAN 304 390 DBREF 5V54 B 37 239 UNP P28222 5HT1B_HUMAN 37 239 DBREF 5V54 B 1001 1105 PDB 5V54 5V54 1001 1105 DBREF 5V54 B 1106 390 UNP P28222 5HT1B_HUMAN 304 390 SEQADV 5V54 TRP A 138 UNP P28222 LEU 138 ENGINEERED MUTATION SEQADV 5V54 TRP B 138 UNP P28222 LEU 138 ENGINEERED MUTATION SEQRES 1 A 395 ASP TYR ILE TYR GLN ASP SER ILE SER LEU PRO TRP LYS SEQRES 2 A 395 VAL LEU LEU VAL MET LEU LEU ALA LEU ILE THR LEU ALA SEQRES 3 A 395 THR THR LEU SER ASN ALA PHE VAL ILE ALA THR VAL TYR SEQRES 4 A 395 ARG THR ARG LYS LEU HIS THR PRO ALA ASN TYR LEU ILE SEQRES 5 A 395 ALA SER LEU ALA VAL THR ASP LEU LEU VAL SER ILE LEU SEQRES 6 A 395 VAL MET PRO ILE SER THR MET TYR THR VAL THR GLY ARG SEQRES 7 A 395 TRP THR LEU GLY GLN VAL VAL CYS ASP PHE TRP LEU SER SEQRES 8 A 395 SER ASP ILE THR CYS CYS THR ALA SER ILE TRP HIS LEU SEQRES 9 A 395 CYS VAL ILE ALA LEU ASP ARG TYR TRP ALA ILE THR ASP SEQRES 10 A 395 ALA VAL GLU TYR SER ALA LYS ARG THR PRO LYS ARG ALA SEQRES 11 A 395 ALA VAL MET ILE ALA LEU VAL TRP VAL PHE SER ILE SER SEQRES 12 A 395 ILE SER LEU PRO PRO PHE PHE TRP ARG GLN ALA LYS ALA SEQRES 13 A 395 GLU GLU GLU VAL SER GLU CYS VAL VAL ASN THR ASP HIS SEQRES 14 A 395 ILE LEU TYR THR VAL TYR SER THR VAL GLY ALA PHE TYR SEQRES 15 A 395 PHE PRO THR LEU LEU LEU ILE ALA LEU TYR GLY ARG ILE SEQRES 16 A 395 TYR VAL GLU ALA ARG SER ARG ILE ALA ASP LEU GLU ASP SEQRES 17 A 395 ARG TRP ARG THR LEU GLU ASP ASN LEU ARG VAL ILE GLU SEQRES 18 A 395 ARG ALA ALA ASN ALA ALA GLU VAL ARG GLU ALA LEU THR SEQRES 19 A 395 ARG MET ARG ALA ALA ALA GLU ASP ALA GLN ARG ALA THR SEQRES 20 A 395 PRO PRO ALA LEU GLU ASP ARG SER PRO ALA SER PRO GLU SEQRES 21 A 395 MET GLU ASP PHE ARG HIS GLY PHE ASP ILE LEU VAL GLY SEQRES 22 A 395 GLN ILE ASP ASP ALA LEU ARG LEU ALA ASP GLU GLY ARG SEQRES 23 A 395 VAL ALA GLU ALA GLN ALA ALA ALA GLU GLU LEU ARG THR SEQRES 24 A 395 THR ARG ASN ALA TYR ILE GLN LYS TYR LEU MET ALA ALA SEQRES 25 A 395 ARG GLU ARG LYS ALA THR LYS THR LEU GLY ILE ILE LEU SEQRES 26 A 395 GLY ALA PHE ILE VAL CYS TRP LEU PRO PHE PHE ILE ILE SEQRES 27 A 395 SER LEU VAL MET PRO ILE CYS LYS ASP ALA CYS TRP PHE SEQRES 28 A 395 HIS LEU ALA ILE PHE ASP PHE PHE THR TRP LEU GLY TYR SEQRES 29 A 395 LEU ASN SER LEU ILE ASN PRO ILE ILE TYR THR MET SER SEQRES 30 A 395 ASN GLU ASP PHE LYS GLN ALA PHE HIS LYS LEU ILE ARG SEQRES 31 A 395 PHE LYS CYS THR SER SEQRES 1 B 395 ASP TYR ILE TYR GLN ASP SER ILE SER LEU PRO TRP LYS SEQRES 2 B 395 VAL LEU LEU VAL MET LEU LEU ALA LEU ILE THR LEU ALA SEQRES 3 B 395 THR THR LEU SER ASN ALA PHE VAL ILE ALA THR VAL TYR SEQRES 4 B 395 ARG THR ARG LYS LEU HIS THR PRO ALA ASN TYR LEU ILE SEQRES 5 B 395 ALA SER LEU ALA VAL THR ASP LEU LEU VAL SER ILE LEU SEQRES 6 B 395 VAL MET PRO ILE SER THR MET TYR THR VAL THR GLY ARG SEQRES 7 B 395 TRP THR LEU GLY GLN VAL VAL CYS ASP PHE TRP LEU SER SEQRES 8 B 395 SER ASP ILE THR CYS CYS THR ALA SER ILE TRP HIS LEU SEQRES 9 B 395 CYS VAL ILE ALA LEU ASP ARG TYR TRP ALA ILE THR ASP SEQRES 10 B 395 ALA VAL GLU TYR SER ALA LYS ARG THR PRO LYS ARG ALA SEQRES 11 B 395 ALA VAL MET ILE ALA LEU VAL TRP VAL PHE SER ILE SER SEQRES 12 B 395 ILE SER LEU PRO PRO PHE PHE TRP ARG GLN ALA LYS ALA SEQRES 13 B 395 GLU GLU GLU VAL SER GLU CYS VAL VAL ASN THR ASP HIS SEQRES 14 B 395 ILE LEU TYR THR VAL TYR SER THR VAL GLY ALA PHE TYR SEQRES 15 B 395 PHE PRO THR LEU LEU LEU ILE ALA LEU TYR GLY ARG ILE SEQRES 16 B 395 TYR VAL GLU ALA ARG SER ARG ILE ALA ASP LEU GLU ASP SEQRES 17 B 395 ARG TRP ARG THR LEU GLU ASP ASN LEU ARG VAL ILE GLU SEQRES 18 B 395 ARG ALA ALA ASN ALA ALA GLU VAL ARG GLU ALA LEU THR SEQRES 19 B 395 ARG MET ARG ALA ALA ALA GLU ASP ALA GLN ARG ALA THR SEQRES 20 B 395 PRO PRO ALA LEU GLU ASP ARG SER PRO ALA SER PRO GLU SEQRES 21 B 395 MET GLU ASP PHE ARG HIS GLY PHE ASP ILE LEU VAL GLY SEQRES 22 B 395 GLN ILE ASP ASP ALA LEU ARG LEU ALA ASP GLU GLY ARG SEQRES 23 B 395 VAL ALA GLU ALA GLN ALA ALA ALA GLU GLU LEU ARG THR SEQRES 24 B 395 THR ARG ASN ALA TYR ILE GLN LYS TYR LEU MET ALA ALA SEQRES 25 B 395 ARG GLU ARG LYS ALA THR LYS THR LEU GLY ILE ILE LEU SEQRES 26 B 395 GLY ALA PHE ILE VAL CYS TRP LEU PRO PHE PHE ILE ILE SEQRES 27 B 395 SER LEU VAL MET PRO ILE CYS LYS ASP ALA CYS TRP PHE SEQRES 28 B 395 HIS LEU ALA ILE PHE ASP PHE PHE THR TRP LEU GLY TYR SEQRES 29 B 395 LEU ASN SER LEU ILE ASN PRO ILE ILE TYR THR MET SER SEQRES 30 B 395 ASN GLU ASP PHE LYS GLN ALA PHE HIS LYS LEU ILE ARG SEQRES 31 B 395 PHE LYS CYS THR SER HET 89F A1201 24 HET 89F B1201 24 HETNAM 89F 1-METHYL-4-[(5~{S})-3-METHYLSULFANYL-5,6- HETNAM 2 89F DIHYDROBENZO[B][1]BENZOTHIEPIN-5-YL]PIPERAZINE HETSYN 89F METHIOTHEPIN, METITEPINE FORMUL 3 89F 2(C20 H24 N2 S2) HELIX 1 AA1 ILE A 39 SER A 43 5 5 HELIX 2 AA2 SER A 45 THR A 77 1 33 HELIX 3 AA3 THR A 82 VAL A 102 1 21 HELIX 4 AA4 VAL A 102 GLY A 113 1 12 HELIX 5 AA5 GLY A 118 ALA A 150 1 33 HELIX 6 AA6 ASP A 153 ARG A 161 1 9 HELIX 7 AA7 THR A 162 GLN A 189 1 28 HELIX 8 AA8 HIS A 205 PHE A 217 1 13 HELIX 9 AA9 PHE A 217 ALA A 1020 1 43 HELIX 10 AB1 ASN A 1022 ALA A 1043 1 22 HELIX 11 AB2 PRO A 1045 ARG A 1051 1 7 HELIX 12 AB3 SER A 1055 GLY A 1082 1 28 HELIX 13 AB4 GLU A 1086 LEU A 1106 1 21 HELIX 14 AB5 MET A 305 MET A 337 1 33 HELIX 15 AB6 HIS A 347 ASN A 373 1 27 HELIX 16 AB7 ASN A 373 ILE A 384 1 12 HELIX 17 AB8 ILE B 39 SER B 43 5 5 HELIX 18 AB9 SER B 45 THR B 77 1 33 HELIX 19 AC1 THR B 82 VAL B 102 1 21 HELIX 20 AC2 VAL B 102 GLY B 113 1 12 HELIX 21 AC3 GLY B 118 ALA B 150 1 33 HELIX 22 AC4 ASP B 153 ARG B 161 1 9 HELIX 23 AC5 THR B 162 ARG B 188 1 27 HELIX 24 AC6 HIS B 205 PHE B 217 1 13 HELIX 25 AC7 PHE B 217 ALA B 1020 1 43 HELIX 26 AC8 ASN B 1022 ALA B 1043 1 22 HELIX 27 AC9 SER B 1055 GLU B 1081 1 27 HELIX 28 AD1 GLN B 1088 LEU B 1106 1 19 HELIX 29 AD2 MET B 305 MET B 337 1 33 HELIX 30 AD3 HIS B 347 ASN B 373 1 27 HELIX 31 AD4 ASN B 373 ILE B 384 1 12 SSBOND 1 CYS A 122 CYS A 199 1555 1555 2.03 SSBOND 2 CYS B 122 CYS B 199 1555 1555 2.03 SITE 1 AC1 14 TRP A 125 LEU A 126 ASP A 129 ILE A 130 SITE 2 AC1 14 CYS A 133 THR A 134 ILE A 137 VAL A 201 SITE 3 AC1 14 THR A 213 TRP A 327 PHE A 330 PHE A 331 SITE 4 AC1 14 THR A 355 TYR A 359 SITE 1 AC2 12 ASP B 129 ILE B 130 CYS B 133 THR B 134 SITE 2 AC2 12 ILE B 137 THR B 213 TRP B 327 PHE B 330 SITE 3 AC2 12 PHE B 331 SER B 334 THR B 355 TYR B 359 CRYST1 235.200 48.830 139.220 90.00 124.07 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004252 0.000000 0.002875 0.00000 SCALE2 0.000000 0.020479 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008671 0.00000